3 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Uveitis, Posterior: new trials by email Literature Review of Uveitis, Posterior trials Research Report on Uveitis, Posterior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravitreal Sirolimus as Therapeutic Approach to Uveitis Intravitreal injection 440mcg, Intravitreal injection of sirolimus 880mcg - Uveitis, Intermediate Uveitis | Phase 2 | Withdrawn | Stanford University | 2022-09-01 | 2023-10-26 | |
| Safety &Efficacy of CF101 to Subjects With Uveitis CF101, Placebo - Uveitis, Posterior, Uveitis, Intermediate | Phase 2 | Withdrawn | Can-Fite BioPharma | 2019-01-01 | 2018-02-01 | |
| A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis Iontophoresis second generation Eyegate II device - Uveitis | Phase 1 / Phase 2 | Withdrawn | Asociación para Evitar la Ceguera en México | 2007-09-01 | 2024-05-30 |
Uveitis (3) · Uveitis, Intermediate (3) · Panuveitis (2) · Uveitis, Anterior (1)
Eye Diseases (3) · Uveal Diseases (3) · Panuveitis (1)
CF101 (1) · Contraceptives, Oral (1) · Intravitreal Injections (1) · N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine (1)
Asociación para Evitar la Ceguera en México (1) · Can-Fite BioPharma (1) · Stanford University (1)
Israel (1) · Mexico (1) · United States (1)
Hugo Quiroz-Mercado, MD (1) · Lourdes Arellanes, MD (1) · Quan D Nguyen, MD, MSc (1) · Raul Velez-Montoya, MD (1)